UnitedHealth Group Inc. has filed a prospectus with the Securities and Exchange Commission related to the issuance of new notes worth a total of $3 billion. The company agreed to sell four sets of notes, including 4.400% Notes due in 2028, 4.650% Notes due in 2031, 5.300% Notes due in 2035, and 5.950% Notes due in 2055. The issuance has been registered under the Securities Act of 1933, with the notes being issued pursuant to an Indenture agreement with U.S. Bank Trust Company. This move is part of UnitedHealth's broader financial strategy, and the related documents have been filed as exhibits to be incorporated into their automatic shelf registration statement.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.